RetinaCME

This activity is expired and is no longer available for CME credit.

EXPERT INTERVIEWCME

On the Scene at ARVO: Interview with Baruch D. Kuppermann, MD, PhD

Author(s)/Faculty: Baruch D. Kuppermann, MD, PhD
Release Date: 5/18/2012Expiration Date: 5/17/2015
Credit Type: CME / ParticipationNumber of Credits: 0
Content Type: Provider:
A single intravitreal dose of 125 µg of ocriplasmin achieved resolution of VMA in approximately 30% of patients. Resolution of this anatomic pathology resulted in clinically significant visual acuity benefits in patients with VMT. Treatment was well tolerated by patients. Ocriplasmin could provide a minimally invasive pharmacologic approach to treat patients with VMT...